Biogen Inc. (BIIB) financial statements (2021 and earlier)

Company profile

Business Address 225 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9062,9141,2253,6894,8953,4291,845
Cash and cash equivalents6272,9141,2251,5742,3271,3081,205
Short-term investments1,279  2,1152,5692,121640
Receivables1,9141,8811,9591,7871,4421,2271,292
Inventory, net of allowances, customer advances and progress billings1,0698049309031,002893804
Inventory1,0698049309031,002893804
Prepaid expense  271    
Other current assets8816316889621,093837447
Other undisclosed current assets1,1182,1522,569533301315283
Total current assets:6,8878,3827,6417,8738,7326,7004,673
Noncurrent Assets
Inventory, Noncurrent  7    
Operating lease, right-of-use asset433427
Property, plant and equipment3,4123,2473,6013,1822,5022,1881,766
Long-term investments and receivables772  3,0572,8292,7601,471
Long-term investments772  3,0572,8292,7601,471
Intangible assets, net (including goodwill)8,8469,2858,8268,5127,4786,7495,789
Goodwill5,7625,7585,7064,6333,6692,6641,760
Intangible assets, net (excluding goodwill)3,0843,5273,1203,8803,8084,0854,029
Deferred income tax assets1,370 
Other noncurrent assets2,8991,2531,6911,0281,3361,108619
Deferred tax assets, net2,154    
Other undisclosed noncurrent assets 4,6401,369    
Total noncurrent assets:17,73218,85317,64815,77914,14512,8059,644
TOTAL ASSETS:24,61927,23425,28923,65322,87719,50514,317
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5976024344645124761,420
Accounts payable455531371396280267229
Accrued liabilities      629
Employee-related liabilities      394
Taxes payable142716468232209168
Debt 1,496 3553
Liability for uncertainty in income taxes      80
Business combination, contingent consideration, liability      266
Deferred revenue and credits   121
Other liabilities3,1452,7662,8612,9012,9042,0971,819
Other undisclosed current liabilities      (1,490)
Total current liabilities:3,7424,8643,2953,3683,4202,5782,220
Noncurrent Liabilities
Long-term debt and lease obligation, including:4026,413  1618563
Long-term debt, excluding current maturities 6,000  6,5566,560563
Operating lease, liability402413
Other undisclosed long-term debt and lease obligation    (6,540)(6,542) 
Liabilities, other than long-term debt2,3622,1523,0261,7518161,0311,150
Accounts payable and accrued liabilities 803    249
Deferred tax liabilities, net1,6361239312551
Deferred income tax liabilities1,033 
Other liabilities1,3301,3491,3891,629723906650
Business combination, contingent consideration, liability      200
Other undisclosed noncurrent liabilities7,4264675,9375,9356,4966,503(430)
Total noncurrent liabilities:10,1919,0318,9627,6867,3287,5521,283
Total liabilities:13,93313,89512,25711,05510,74810,1303,503
Stockholders' equity
Stockholders' equity attributable to parent10,70013,34313,04012,61312,1409,37310,809
Common stock0000000
Treasury stock, value(2,977)(2,977)(2,977)(2,977)(2,612)(2,612)(2,612)
Additional paid in capital   98  4,196
Accumulated other comprehensive loss(299)(135)(240)(318)(320)(224)(59)
Retained earnings13,97616,45516,25715,81015,07212,2089,284
Stockholders' equity attributable to noncontrolling interest(14)(4)(8)(15)(12)25
Total stockholders' equity:10,68613,33913,03212,59812,1299,37510,814
TOTAL LIABILITIES AND EQUITY:24,61927,23425,28923,65322,87719,50514,317

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues13,44514,37813,45312,27411,44910,7649,703
Revenue, net10,71510,1349,4258,508
Cost of revenue(2,417)(2,623)(2,736)(1,805)(1,527)(1,282)(1,222)
Cost of goods and services sold(1,805)(1,955)(1,816)(1,707)(1,527)(1,282)(1,222)
Other undisclosed gross profit611668920175484251
Gross profit:11,63912,42311,63710,6449,9709,5238,532
Operating expenses(6,478)(4,712)(4,828)(5,125)(4,795)(4,602)(4,666)
Other undisclosed operating income (loss)(611)(668)(920)(175)(25)(31)107
Operating income:4,5507,0435,8895,3445,1504,8913,972
Nonoperating income (expense)4978311(215)(217)(124)(24)
Investment income, nonoperating4212011379  13
Foreign currency transaction gain (loss), before tax(11)(7)(10)6  (12)
Other nonoperating income (expense)3(47)(11)(13)(217)(124)(26)
Interest and debt expense(223)(187)(201)(251)(260)(96)(30)
Other undisclosed income from continuing operations before equity method investments, income taxes2231872012512609628
Income from continuing operations before equity method investments, income taxes:5,0487,1265,9005,1294,9334,7673,947
Income (loss) from equity method investments3(79)   (13)(15)
Income from continuing operations before income taxes:5,0517,0475,9005,1294,9334,7553,932
Income tax expense(992)(1,158)(1,426)(2,459)(1,237)(1,162)(990)
Income before gain (loss) on sale of properties:4,0595,8894,4742,6703,6963,5932,942
Other undisclosed net income2      
Net income:4,0615,8894,4742,6703,6963,5932,942
Net income (loss) attributable to noncontrolling interest(60) (43)(131)7(46)(7)
Net income available to common stockholders, diluted:4,0015,8894,4312,5393,7033,5472,935

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:4,0615,8894,4742,6703,6963,5932,942
Other comprehensive income (loss)(163)10576(2)9616532
Other undisclosed comprehensive income (loss)   3(192)(329)(63)
Comprehensive income:3,8985,9934,5502,6723,6003,4292,910
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(61)0(43)131(7)467
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (262)14(92)(14)
Comprehensive income, net of tax, attributable to parent:3,8375,9944,5072,5413,6073,3832,903

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: